Longitudinal analysis of cytokines and chemokines in the cerebrospinal fluid of a patient with neuro-sweet disease presenting with recurrent encephalomeningitis

Internal Medicine

Volumn 47, Issue 3, 2008, Pages 135-141

  Kimura, Akio ^a   Sakurai, Takeo ^a   Koumura, Akihiro ^a   Suzuki, Yoshihiro ^a   Tanaka, Yuji ^a   Hozumi, Isao ^a   Nakajima, Hideto ^b   Ichiyama, Takashi ^c   Inuzuka, Takashi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CXCL10 (IP 10); CXCL8 (IL 8); IFN y; IL 6; Neutrophil cell; Th1 cell

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CHEMOKINE; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHENYTOIN; PREDNISOLONE; PROPOFOL; RANTES; TUMOR NECROSIS FACTOR ALPHA; 5(4' HYDROXYBENZYLIDENOIMINO) 3 METHYLISOTHIAZOLO(5,4 D)PYRIMIDINE (7H) 4,6 DIONE; 5(4'-HYDROXYBENZYLIDENOIMINO)-3-METHYLISOTHIAZOLO(5,4-D)PYRIMIDINE-(7H)-4,6-DIONE; PYRIMIDINONE DERIVATIVE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; GRAND MAL SEIZURE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LONGITUDINAL STUDY; MENINGOENCEPHALITIS; MONONUCLEAR CELL; NEURO SWEET DISEASE; NEUROLOGIC DISEASE; NEUTROPHIL COUNT; POSTVACCINAL ENCEPHALITIS; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL; TONIC SEIZURE; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; CEREBROSPINAL FLUID; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKIN-8; MENINGOENCEPHALITIS; MIDDLE AGED; PYRIMIDINONES; RECURRENCE; SWEET'S SYNDROME; TH1 CELLS; TH2 CELLS; THIAZOLES;

EID: 39749168410     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0370     Document Type: Article

References (27)

1. Hisanaga K, Hosokawa M, Sato N, Mochizuki H, Itoyama Y, Iwasaki Y. "Neuro-Sweet disease": Benign recurrent encephalitis with neutrophilic dermatosis. Arch Neurol 56: 1010-1013, 1999.
2. Hisanaga K, Iwasaki Y, Itoyama Y, Neuro-Sweet Disease; Study Group. Neuro-Sweet disease: Clinical manifestations and criteria for diagnosis. Neurology 64: 1756-1761, 2005.
3. Mizoguchi M, Matsuki K, Mochizuki M, et al. Human leukocyte antigen in Sweet's syndrome and its relationship to Behçet's disease. Arch Dermatol 124: 1069-1073, 1998.
4. Noda K, Okuma Y, Fukae J, et al. Sweet's syndrome associated with encephalitis. J Neurol Sci 188: 95-97, 2001.
5. Druschky A, von den Dreisch P, Anders M, Claus D, Neundorfer B. Sweet's sndrome (acute febrile neutrophilic dermatosis) affecting the central nervous system. J Neurol 243: 556-557, 1996.
6. Chen R, Lowe L, Wilson JD, et al. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem 45: 1693-1694, 1999.
7. Cook EB, Stahl JL, Lowe L, et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods 254: 109-118, 2001.
8. Metelitsa LS, Naidenko OV, Kant A, et al, Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 167: 3114-3122, 2001.
9. Nakajima H, Fukuda K, Doi Y, et al. Expression of THI/TH2-related chemokine, receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis. Eur Neurol 52: 162-168, 2004.
10. Romagnani S. The Th1/Th2 paradigm. Immunol Today 18: 263-266, 1997.
11. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173, 1989.
12. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 383: 787-793, 1996.
13. Giasuddin AS, El-Orfi AH, Ziu MM, El-Barnawi NY. Sweet's syndrome: Is the pathogenesis mediated by helper T cell type 1 cytokines? J Am Acad Dermatol 39: 940-943, 1998.
14. Nifosi G. Sweet syndrome: personal experience and review of the literature. Minerva Med 92: 49-55, 2001.
15. Park JW, Mehrotra B, Barnett BO, Baron AD, Venook AP. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med 116: 996-998, 1992.
16. Kumar G, Bernstein JM, Waibel JS, Baumann MA. Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Am J Hematol 76: 283-285, 2004.
17. Watarai K, Tojo A, Nagamura-Inoue T, et al. Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia: a case report with in vitro studies. Cancer 89: 551-560, 2000.
18. Iwatsuki K, Deguchi K, Narai H, et al. A case of neuro-Behçt's disease with HLA B54 and predominant cerebral white matter lesions. Rinsho Shinkeigaku 40: 921-925, 2000 (in Japanese).
19. Uysal H, Vahaboglu H, Inan L, Vahaboglu G. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in neuro-Behçet's disease. Clin Neurol Neurosurg 95: 319-322, 1993.
20. International Study, Group for Behçet's Disease. Criteria for diagnosis of Behçet disease. Lancet 335: 1078-1080, 1990.
21. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease. A putative pathogenetic role of interleukin-12. Arthritis Rheum 42: 1967-1974, 1999.
22. Raziuddin S, Al-Dalaan A, Bahabri S, Siraj AK, al-Sedairy S. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 25: 329-333, 1998.
23. al-Dalaan A, al-Sedairy S, al-Balaa S, et al. Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease. J Rheumatol 22: 904-907, 1995.
24. Gur-Toy G, Lenk N, Yalcin B, Aksaray S, Alli N. Serum interleukin-8 as a serologic marker of activity in Behçet's disease. Int J Dermatol 44: 657-660, 2005.
25. Hirohata S, Isshi K, Oguchi H, et al. Cerebrospinal fluid interleukin-6 in progressive neuro-Behçet's syndrome. Chn Immunol Immunopathol 82: 12-17, 1997.
26. Hirayama M, Kiyosawa K, Nakazaki S, Fujiki N, Iida M. Measurement of gamma-interferon in sera and CSF in patients with multiple sclerosis and inflammatory neurological diseases. Rinsho Shinkeigaku 30: 557-559, 1990 (in Japanese).
27. Markowiitz CE. Interferon-beta: Mechanism of action and dosing issues. Neurology 68: 8-11, 2007.